Researchers found that a condition called clonal hematopoiesis of indeterminate potential (CHIP) is linked to accelerated aging. CHIP occurs when mutations in blood stem cells lead to the production of immune cells with genetic changes. This process can result in a higher epigenetic age, which is a measure of biological aging based on DNA changes. In a review of five studies involving nearly 7,500 adults aged 55 to 79, those with CHIP showed an increased epigenetic age compared to those without it.

Understanding CHIP is important because it may help explain why some people experience age-related health issues more quickly than others. The findings suggest that if you have CHIP, you might be aging faster at a cellular level, which could lead to a higher risk of diseases and health problems. Specifically, individuals with CHIP had an average epigenetic age that was 1.20 to 2.84 years older than their chronological age, indicating a potential marker for assessing health risks as you age.

The evidence comes from a systematic review that analyzed data from multiple studies but is still in early stages. While the results are compelling, they are based on observational data rather than large-scale trials. More research is needed to confirm these findings and explore how CHIP might influence health outcomes over time. This means while the connection between CHIP and accelerated aging is promising, it is not yet fully understood how it impacts overall health and longevity.

Source: fightaging.org